Biologics for Psoriasis in Iraq: Benefits & Barriers - Tapa blanda

Introduction of these drugs in treating patients with psoriasis in some of the hospitals in Baghdad will help those patients a lot, improving their quality of life and decreasing the morbidity caused by psoriasis and many of the conventional drugs used to treat it. They could be introduced for those for whom many of these conventional drugs are ineffective or contraindicated as a result of their effects on different organs of the body. The aim of this project is to explore the feasibility and the possibility of the introduction of biological drugs as one of the treatment options for psoriasis in Alkarama teaching hospital in Baghdad. This project has many objectives. Firstly, to assess the readiness of hospitals in Baghdad for the introduction of biological drugs. Secondly, to try to establish the suitability of using biological drugs for psoriasis in Iraq. Thirdly, to decrease the cumulative side effects of conventional systemic antipsoriatic drugs by switching to biologics for a certain period of time as part of rotational therapy or combined therapy strategies.

· Omar T. Mohammed Al-Janabi.· Born in 1976 – Iraq.· Graduated from the Medical School of Baghdad University in 2000.· Gained MSc Dermatology Skills & Treatment from the University of Hertfordshire in the United Kingdom in 2011.· Worked in many hospitals in Baghdad and had placement in many hospital in England.